Features of Top Medical Device Companies

The 6 lines of code that could bring down a hospital

March 11, 2013 by Arezu Sarvestani

The software flaw that allowed a duo of cybersecurity researchers to bring down a Philips XPER hospital management system with 6 lines of code is still a problem in current XPER machines, Philips tells MassDevice.com.

cybersecurity, hacking illustration

Using fairly rudimentary hacking techniques, researchers have exposed vulnerabilities in a variety of medical devices, most recently in a Philips (NYSE:PHG) Xper hospital management system that buckled under the force of a mere 6 lines of code.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific's APAC VP on the playbook for China and India

February 20, 2013 by Brian Johnson

MassDevice.com discusses Boston Scientific's playbook for China, India, Russia and Brazil with Asia-Pacific president Supratim Bose.

Global Medicine

In the summer of 2011, Boston Scientific (NYSE:BSX) committed $150 million to a 5-year plan to expand its Chinese operations, aiming to increase its workforce there 6-fold to more than 1,200 boost its R&D and clinical study spend.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific CFO: 'The portfolio is there. Now it's all about execution'

February 13, 2013 by Brian Johnson

Boston Scientific CFO Jeffrey Capello tells MassDevice.com how the medical device company plans to pull itself out of one of the roughest patches in its history.

Boston Scientific CFO Jeffrey Capello

MassDevice.com sat down with Boston Scientific (NYSE:BSX) CFO Jeffrey Capello in New York City this week on the heels of the medical device company's analyst day to discuss its outlook for 2013 and beyond.

Direct Flow aims to use heart valve giants' experience against them

February 12, 2013 by Arezu Sarvestani

Direct Flow Medical and CEO Bernie Lyons are betting that its heart valve technology can use the decade's worth of experience of the medical device industry's transcatheter aortic valve implant pioneers to leapfrog the competition.

Direct Flow Medical CEO Bernie Lyons

Being one of the smallest players on the field means you've got to differentiate yourself to stand out against the titans of the game, and that's what Direct Flow Medical CEO Bernie Lyons aims to do.

'Healthcare is grossly under-engineered,' says Johns Hopkins' Pronovost (podcast)

January 18, 2013 by Arezu Sarvestani

Johns Hopkins patient safety expert Peter Pronovost on medical errors, medical device data and the role medtech must accept in preventing needless deaths.

Peter Pronovost of Johns Hopkins Medical

Healthcare providers are looking to medical devices to play a new role in hospital care, providing a whole-patient view of health through technologies that talk to each other and help clinicians make decisions about treatment.

Patient safety: Q&A with Masimo founder Joe Kiani

January 14, 2013 by Arezu Sarvestani

Masimo founder & CEO Joe Kiani tells MassDevice.com how closed healthcare data leads to patient injuries and deaths and the business reasons that the data has stayed closed for so long.

Masimo founder and CEO Joe Kiani

Healthcare companies are running out of reasons to keep their data behind closed doors, according to Masimo (NSDQ:MASI) founder & CEO Joe Kiani.

Zoll CEO Packer on device tax repeal efforts: No pessimists on the front lines

December 20, 2012 by Arezu Sarvestani

Zoll CEO Rick Packer says that tax repeal advocates on the front lines of the discussions with Washington are optimistic that the levy on device makers will be addressed before it hits in January.

Zoll CEO Richard Packer

As the medical device excise tax creeps closer to its planned launch date, all eyes are on Congress to see whether medtech lobbying efforts will yield a win for the industry.

While lawmakers weigh the tax and argue their way toward the so-called fiscal cliff, device industry stakeholders are placing their bets on whether or not the excise tax will survive until January.

Strathspey Crown and the first Medicare-Medicaid opt-out company in medtech | A conversation with Robert Grant

December 3, 2012 by Brian Johnson

In this MassDevice Big 100 West preview, we talk to Strathspey Crown Chairman Robert Grant about how his private equity firm Strathspey Crown is looking to break the mold.

Strathspey Crown CEO Robert Grant

If Robert Grant is successful – a good bet, judging by his track record – 1 day his new venture, private equity firm Strathspey Crown, will be known as a leader in the nascent field of "lifestyle medicine."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Invisalign trailblazes a path direct to the consumer| A conversation with Align Technology CEO Tom Prescott

November 28, 2012 by Brian Johnson

In this MassDevice Big 100 West preview we talk to Align Technology CEO Tom Prescott about how Invisalign crossed the chasm into mainstream culture through social media and aggressive consumer marketing strategies.

Align Technology CEO Tom Prescott

Crooked-toothed teens may want to consider sliding a picture of Tom Prescott next to that fading "Twilight" poster on the wall.

Sanovas seeks $25 million as it gears up to go commercial

November 13, 2012 by Brad Perriello

Medical device company Sanovas is looking to raise about $25 million to commercialize its next-generation Vas Zeppelin pulmonary device designed to scan, diagnose and treat lung disease in a single sitting.

Sanovas CEO Larry Gerrans

Most startup medical device companies raise 10s of millions to research and develop their products before they even get to the commercial stage. But for Sanovas and co-founder Larry Gerrans, the 12-year journey to that point required a scant $9 million – all raised from the pulmonary device firm's founders, friends and family, Gerrans told MassDevice.com last month.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp